Publication:
Therapeutic Potential of Isoflavones with an Emphasis on Daidzein

dc.contributor.authorAlshehri, Mohammed M
dc.contributor.authorSharifi-Rad, Javad
dc.contributor.authorHerrera-Bravo, Jesus
dc.contributor.authorJara, Evelyn L
dc.contributor.authorSalazar, Luis A
dc.contributor.authorKregiel, Dorota
dc.contributor.authorUprety, Yadav
dc.contributor.authorAkram, Muhammad
dc.contributor.authorIqbal, Mehwish
dc.contributor.authorMartorell, Miquel
dc.contributor.authorTorrens-Mas, Margalida
dc.contributor.authorPons, Daniel Gabriel
dc.contributor.authorDastan, Sevgi Durna
dc.contributor.authorCruz-Martins, Natalia
dc.contributor.authorOzdemir, Fethi Ahmet
dc.contributor.authorKumar, Manoj
dc.contributor.authorCho, William C
dc.date.accessioned2024-09-18T06:42:42Z
dc.date.available2024-09-18T06:42:42Z
dc.date.issued2021-09-10
dc.description.abstractDaidzein is a phytoestrogen isoflavone found in soybeans and other legumes. The chemical composition of daidzein is analogous to mammalian estrogens, and it could be useful with a dual-directional purpose by substituting/hindering with estrogen and estrogen receptor (ER) complex. Hence, daidzein puts forth shielding effects against a great number of diseases, especially those associated with the control of estrogen, such as breast cancer, diabetes, osteoporosis, and cardiovascular disease. However, daidzein also has other ER-independent biological activities, such as oxidative damage reduction acting as an antioxidant, immune regulator as an anti-inflammatory agent, and apoptosis regulation, directly linked to its potential anticancer effects. In this sense, the present review is aimed at providing a deepen analysis of daidzein pharmacodynamics and its implications in human health, from its best-known effects alleviating postmenopausal symptoms to its potential anticancer and antiaging properties.en
dc.description.sponsorshipN.M. acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017). M. T-M was funded by a grant from the Programa Postdoctoral Margalida ComasComunidad Autonoma de las Islas Baleares (PD/050/2020). The authors also acknowledge that some of the icons used in figures are adapted from Flaticon.es_ES
dc.format.page6331630es_ES
dc.format.volume2021es_ES
dc.identifier.citationAlshehri MM, Sharifi-Rad J, Herrera-Bravo J, Jara EL, Salazar LA, Kregiel D, et al. Therapeutic Potential of Isoflavones with an Emphasis on Daidzein. Oxidative Med Cell Longev. 2021 Sep 10;2021:6331630.en
dc.identifier.doi10.1155/2021/6331630
dc.identifier.e-issn1942-0994es_ES
dc.identifier.issn1942-0900
dc.identifier.journalOxidative Medicine and Cellular Longevityes_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/19873
dc.identifier.pubmedID34539970es_ES
dc.identifier.puiL2014746679
dc.identifier.scopus2-s2.0-85115813446
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23222
dc.identifier.wos697318600001
dc.language.isoengen
dc.publisherHindawi
dc.relation.publisherversionhttps://dx.doi.org/10.1155/2021/6331630en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.decsAnimales*
dc.subject.decsSoja*
dc.subject.decsHumanos*
dc.subject.decsNeoplasias*
dc.subject.decsOsteoporosis*
dc.subject.decsEstrés Oxidativo*
dc.subject.decsEnfermedades Cardiovasculares*
dc.subject.decsIsoflavonas*
dc.subject.decsFármacos Neuroprotectores*
dc.subject.meshCardiovascular Diseases*
dc.subject.meshOxidative Stress*
dc.subject.meshIsoflavones*
dc.subject.meshAnimals*
dc.subject.meshHumans*
dc.subject.meshNeuroprotective Agents*
dc.subject.meshNeoplasms*
dc.subject.meshOsteoporosis*
dc.subject.meshSoybeans*
dc.titleTherapeutic Potential of Isoflavones with an Emphasis on Daidzeinen
dc.typereview articleen
dspace.entity.typePublication
relation.isPublisherOfPublication9af49786-d444-4e47-b90c-0ef0dc2badd3
relation.isPublisherOfPublication.latestForDiscovery9af49786-d444-4e47-b90c-0ef0dc2badd3

Files